Pairing amylin drug eloralintide with tirzepatide beat tirzepatide alone at 14.8%, but up to about a quarter quit over side effects. Lilly says Phase 3 is next.
Recap by typeshit. Full story at New Atlas.
U of T researchers built the AI tool with the aim of speeding up how new peptide drugs are found. The university's announcement has the details.
Fractyl plans to file a De Novo request with the FDA in late Q4, yet its shares closed about 63% lower that day over a class action and doubts about 12-month results.
Health records from 131 million adults linked GLP-1s to fewer dialysis or transplant cases. The researchers stress the study is observational and can't prove cause.
Centre Daily Times looks at how peptides taken by mouth can get past the gut intact and reach specific spots in the body, a key hurdle for pill versions of these drugs.
About 180 people will get MRI scans during food and money tasks through March 2027. Noom is funding the research led by neuroscientist Michael Platt.
A quick rundown aimed at people just starting GLP-1 treatment, covering the changes they might notice and ways to get ready for them.
Loading…